首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >S-16924 ((R)-2-(1-(2-(2,3-dihydro-benzo(1,4)dioxin-5-yloxy)-ethyl)- pyrrolidin-3yl)-1-(4-fluorophenyl)-ethanone), a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and ha
【24h】

S-16924 ((R)-2-(1-(2-(2,3-dihydro-benzo(1,4)dioxin-5-yloxy)-ethyl)- pyrrolidin-3yl)-1-(4-fluorophenyl)-ethanone), a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and ha

机译:S-16924((R)-2-(1-(2-(2-(2,3-二氢-苯并(1,4)二恶英-5-基氧基)-乙基)-吡咯烷-3-基)-1-(4-氟苯基)-乙酮),一种新型的潜在抗精神病药,具有显着的5-羟色胺1A激动剂特性:III。与氯氮平和ha相比的抗焦虑作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

S-16924 is a potential antipsychotic that displays agonist and antagonist properties at serotonin (5-HT)1A and 5-HT2A/2C receptors, respectively. In a pigeon conflict procedure, the benzodiazepine clorazepate (CLZ) increased punished responses, an action mimicked by S-16924, whereas the atypical antipsychotic clozapine and the neuroleptic haloperidol were inactive. Similarly, in a Vogel conflict paradigm in rats, CLZ increased punished responses, an action shared by S-16924 but not by clozapine or haloperidol. This action of S-16924 was abolished by the 5-HT1A antagonist WAY-100,635. Ultrasonic vocalizations in rats were inhibited by CLZ, S-16924, clozapine, and haloperidol. However, although WAY-100,635 abolished the action of S-16924, it did not affect clozapine and haloperidol. In a rat elevated plus-maze, CLZ, but not S-16924, clozapine, and haloperidol, increased open-arm entries. Like CLZ, S-16924 increased social interaction in rats, whereas clozapine and haloperidol were inactive. WAY-100,635 abolished this action of S-16924. CLZ, S-16924, clozapine, and haloperidol decreased aggressive interactions in isolated mice, but this effect of S-16924 was not blocked by WAY-100, 635. All drugs inhibited motor behavior, but the separation to anxiolytic doses was more pronounced for S-16924 than for CLZ. Finally, in freely moving rats, CLZ and S-16924, but not clozapine and haloperidol, decreased dialysis levels of 5-HT in the nucleus accumbens: this action of S-16924 was blocked by WAY-100,165. In conclusion, in contrast to haloperidol and clozapine, S-16924 possessed a broad-based profile of anxiolytic activity at doses lower than those provoking motor disruption. Its principal mechanism of action was activation of 5-HT1A (auto)receptors.
机译:S-16924是一种潜在的抗精神病药,在5-羟色胺(5-HT)1A和5-HT2A / 2C受体上分别表现出激动剂和拮抗剂特性。在鸽子冲突程序中,苯二氮卓类药物氯氮平(CLZ)增加了受罚的反应,这一作用被S-16924模仿,而非典型的抗精神病药物氯氮平和抗精神病药物氟哌啶醇则没有活性。类似地,在大鼠的Vogel冲突范例中,CLZ增加了受罚的反应,S-16924共有这种作用,但氯氮平或氟哌啶醇则没有。 S-16924的这一作用已被5-HT1A拮抗剂WAY-100,635取消。大鼠的超声波发声被CLZ,S-16924,氯氮平和氟哌啶醇抑制。然而,尽管WAY-100,635取消了S-16924的作用,但它并未影响氯氮平和氟哌啶醇。在老鼠高架迷宫中,CLZ而不是S-16924,氯氮平和氟哌啶醇会增加张开臂的进入。与CLZ一样,S-16924可增加大鼠的社交互动,而氯氮平和氟哌啶醇则不活跃。 WAY-100,635废除了S-16924的这一动作。 CLZ,S-16924,氯氮平和氟哌啶醇减少了离体小鼠的侵袭性相互作用,但WAY-100、635并未阻止S-16924的这种作用。所有药物均能抑制运动行为,但对于抗焦虑剂的分离对S-16924比CLZ好。最后,在自由活动的大鼠中,CLZ和S-16924而非氯氮平和氟哌啶醇在伏隔核中降低了5-HT的透析水平:WAY-100,165阻止了S-16924的这一作用。总之,与氟哌啶醇和氯氮平相比,S-16924的抗焦虑活性基础广泛,其剂量低于引起运动破坏的剂量。它的主要作用机制是激活5-HT1A(自身)受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号